PIQLF (Proteomics International Laboratories) Price-to-Operating-Cash-Flow: (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PIQLF Proteomics International Laboratories Ltd PIQLF
13 GF Score
Price $0.12
GF Value $0.39
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Proteomics International Laboratories Price-to-Operating-Cash-Flow?

As of today (2026-09-17), Proteomics International Laboratories's share price is $0.1248. Proteomics International Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.02. Hence, Proteomics International Laboratories's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Proteomics International Laboratories's Price-to-Operating-Cash-Flow or its related term are showing as below:

PIQLF's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 22.41
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Proteomics International Laboratories's Cash Flow from Operations per share for the six months ended in Dec. 2025 was $-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -10.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -9.30% per year.

During the past 12 years, Proteomics International Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.10% per year. The lowest was -130.50% per year. And the median was -6.90% per year.

Proteomics International Laboratories Price-to-Operating-Cash-Flow Related Terms

Proteomics International Laboratories Price-to-Operating-Cash-Flow Historical Data

* Premium members only.

The historical data trend for Proteomics International Laboratories's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteomics International Laboratories Price-to-Operating-Cash-Flow Chart

Proteomics International Laboratories Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Proteomics International Laboratories Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PIQLF vs VRTX, REGN, MRNA: Price-to-Operating-Cash-Flow Comparison

For the Biotechnology subindustry, Proteomics International Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proteomics International Laboratories Price-to-Operating-Cash-Flow vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's Price-to-Operating-Cash-Flow falls into.


PIQLF
13GF Score
Proteomics International Laboratories Ltd PIQLF
Price-to-Operating-Cash-Flow is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Proteomics International Laboratories Price-to-Operating-Cash-Flow Calculation

Proteomics International Laboratories's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.1248/-0.023
=

Proteomics International Laboratories's Share Price of today is $0.1248.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Proteomics International Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Is Proteomics International Laboratories (PIQLF) Overvalued in 2026?

Based on GuruFocus' analysis, Proteomics International Laboratories stock appears to be undervalued. The current stock price of $0.12 is trading 68% below its estimated GF Value™ of $0.39. GuruFocus considers Proteomics International Laboratories to be Possible Value Trap.

Key valuation signals for PIQLF:

  • Price-to-Operating-Cash-Flow:
  • GF Value™: $0.39 vs. price of $0.12 (68% below fair value)
  • GF Score™: 13/100 with 7 warning signs

No single metric tells the full story. See the PIQLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Proteomics International Laboratories Business Description

Other Exchanges PIQ:Australia
Address 6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx.
13GF Score

Get the complete analysis for PIQLF

Price-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price
$0.39
GF Value